ALT activation is described in sarcoma, astrocytoma, neuroblastoma, and carcinoma [18] cases as well as CM [16] and is related to functional loss of ATRX and/or histone H3.3 chaperone DAXX. This evidence concerns the gene DAXX and cutaneous mastocytosis.